Wroclaw Medical University

Research in this area focuses on relapsed/refractory B-cell malignancies and non-Hodgkin lymphomas, reflecting a strong interest in blood-related cancers. The trials are designed to assess new treatment options and better understand how to improve outcomes for patients with difficult-to-treat disease.

• Relapsed/refractory B-cell malignancies
• Non-Hodgkin lymphomas
• Diffuse large B-cell lymphoma and other aggressive B-cell subtypes

At this site, the research aims to evaluate innovative therapies that may offer more effective control of these cancers and support future treatment advances.

The oncology portfolio includes studies of B-cell non-Hodgkin lymphomas and related aggressive lymphoma subtypes, with a focus on testing promising new approaches for cancer care. These trials explore whether emerging therapies can improve disease control in patients with limited treatment options.

• B-cell non-Hodgkin lymphomas
• Diffuse large B-cell lymphoma
• High-grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement

The work supports the development of more targeted and potentially more effective cancer treatments in a specialized academic setting.

Neurology research at Wroclaw Medical University includes a study of seizures associated with PNPO deficiency, a rare condition affecting the nervous system. The trial is intended to evaluate a treatment approach for long-term symptom control and to improve care for patients with this uncommon disorder.

• Seizures associated with PNPO deficiency
• Rare pediatric neurological disease
• Chronic treatment support for seizure management

This area of research highlights the site’s involvement in both rare disease care and efforts to improve treatment effectiveness for affected patients.